About US
Contact us
-
SFDA:Application and approval procedure for clinical trialsSource: Web of SFDA2009/12/17
-
BASF increases prices in Europe for Dimethylaminopropylamine and DimethylacetamideWith immediate effect , BASF is increasing the sales prices for the Methylamines derivatives Dimethylaminopropylamine (DMAPA) and Dimethylacetamide (DMAc) in Europe as follows: Dimethylaminopropyla2009/12/17
-
Tris Pharma Announces NDA Approvals From FDA, Including First-Ever 24-Hour Liquid Sustained-Release ProductTris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, recently announced that the US FDA has approved its first two NDAs based on its proprietary OralXR+2009/12/17
-
Azopharma Refocuses on Core Capabilities & Restructures ManagementAzopharma Product Development Group has integrated its services to offer a more streamlined approach to product development. Focus has returned to Azopharma’s core capabilities, including prec2009/12/16
-
2010 Annual IPEC Europe Seminar – January 28, 20102010 Annual IPEC Europe Seminar – January 28, 2010, Gray d’Albion Hotel Cannes, France Provisional Program “Taking Excipients into the Next Decade” Keynote Address: Pharmacopoeias in the 21s2009/12/16
-
DAVISCO Foods & MEGGLE Announce Joint VentureAnnounced this past by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, an2009/12/16
-
Debating the risks of advanced therapiesDo advanced therapies represent medical miracles or risky business? This is the question that is debated by an Informa analyst in an Executive Briefing for Scrip. New EU rules concerning the develop2009/12/15
-
The NEW Dow Adhesives to Debut @ Label Expo Asia 2009SHANGHAI--(BUSINESS WIRE)--When two world-class pressure sensitive adhesive (PSA) forces come together, a PSA powerhouse is bound to be formed. Dow Adhesives and Functional Polymers, a business unit o2009/12/15
-
ISP to increase prices on 1,4 Butanediol and derivatives, including: N-Methyl-2-Pyrrolidone (NMP), Gamma-Butyrolactone (BLO), and Tetrahydrofuran (THF) prices globally. Effective December 10, 2009.Wayne, N.J. – December 10, 2009International Specialty Products Inc. (“ISP”) has announced a global price increase for 1,4 Butanediol (BDO) and derivatives, including: N-Methyl-2-Pyrrolidone (2009/12/15
-
SFDA solicits opinions on revised Good Manufacturing Practice for Pharmaceutical Products (GMP) a second timeSince soliciting opinions on revised Good Manufacturing Practice for Pharmaceutical Products (draft for comment) in September 2009, the State Food and Drug Administration (SFDA) has received t2009/12/14